InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
6
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Krieg Arthur M, Directeur scientifique. Officer active across 1 company, notably Checkmate Pharmaceuticals, Inc.. In total, 8 filings have been recorded. Breakdown: 6 buys · 0 sell. Total volume traded: €395k. Activity tracked since 18 May 2021. The latest transaction was filed on 18 June 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations8 total
7,224 shares@ US$6.049.3% of flowCommon StockSEC:0000899243-21-024984
Ideal exit: 15 Mar 2022 (T+270)
7,224 shares@ US$6.049.3% of flowCommon StockSEC:0000899243-21-024984:0
Ideal exit: 15 Mar 2022 (T+270)
3,578 shares@ US$6.184.7% of flowCommon StockSEC:0000899243-21-024427
Ideal exit: 13 Mar 2022 (T+270)
3,578 shares@ US$6.184.7% of flowCommon StockSEC:0000899243-21-024427:0
Ideal exit: 13 Mar 2022 (T+270)
68,457 shares0Common StockSEC:0000899243-21-021392
68,457 shares0Common StockSEC:0000899243-21-021392:0
25,001 shares@ US$6.9736.1% of flowCommon StockSEC:0000899243-21-019922
Ideal exit: 12 Feb 2022 (T+270)
25,001 shares@ US$6.9736.1% of flowCommon StockSEC:0000899243-21-019922:0
Ideal exit: 12 Feb 2022 (T+270)
8 of 8 declarations
About Krieg Arthur M
Arthur M. Krieg is the Chief Scientific Officer at Checkmate Pharmaceuticals, Inc. He oversees the company's research and development activities, ensuring innovation and compliance with scientific standards. Krieg plays a key role in advancing research projects and achieving strategic objectives.
